Hamid Sayar

1.7k total citations
36 papers, 648 citations indexed

About

Hamid Sayar is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, Hamid Sayar has authored 36 papers receiving a total of 648 indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Hematology, 13 papers in Molecular Biology and 6 papers in Genetics. Recurrent topics in Hamid Sayar's work include Acute Myeloid Leukemia Research (28 papers), Histone Deacetylase Inhibitors Research (9 papers) and Chronic Myeloid Leukemia Treatments (7 papers). Hamid Sayar is often cited by papers focused on Acute Myeloid Leukemia Research (28 papers), Histone Deacetylase Inhibitors Research (9 papers) and Chronic Myeloid Leukemia Treatments (7 papers). Hamid Sayar collaborates with scholars based in United States, France and Spain. Hamid Sayar's co-authors include Ornella Semino, R. Spencer Wells, Lluís Quintana‐Murci, Nadia Al-Zahery, Aisha Mohyuddin, Chiara Rengo, Doron M. Behar, Alfredo Coppa, A. Silvana Santachiara‐Benerecetti and S. Qasim Mehdi and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Hamid Sayar

34 papers receiving 629 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hamid Sayar United States 11 269 250 169 125 71 36 648
Lucia Casarino Italy 13 87 0.3× 162 0.6× 323 1.9× 11 0.1× 163 2.3× 26 608
Giuseppe Lentini Germany 10 95 0.4× 124 0.5× 109 0.6× 3 0.0× 61 0.9× 27 659
Costanza Bosi Italy 13 35 0.1× 281 1.1× 385 2.3× 4 0.0× 210 3.0× 25 630
J.C. Murray United States 10 178 0.7× 266 1.1× 29 0.2× 3 0.0× 26 0.4× 15 587
Steven Fabian United States 7 72 0.3× 209 0.8× 9 0.1× 7 0.1× 22 0.3× 13 398
Marion E. Stone United States 4 37 0.1× 146 0.6× 422 2.5× 4 0.0× 321 4.5× 6 589
Chimene Kesserwan United States 14 224 0.8× 240 1.0× 153 0.9× 91 1.3× 24 661
Sachiyo Nishida Japan 15 289 1.1× 247 1.0× 319 1.9× 66 0.9× 47 773
Matthew E. Mealiffe United States 8 206 0.8× 140 0.6× 216 1.3× 71 1.0× 10 669
Sarah A. Bannon United States 14 180 0.7× 166 0.7× 263 1.6× 119 1.7× 33 743

Countries citing papers authored by Hamid Sayar

Since Specialization
Citations

This map shows the geographic impact of Hamid Sayar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hamid Sayar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hamid Sayar more than expected).

Fields of papers citing papers by Hamid Sayar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hamid Sayar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hamid Sayar. The network helps show where Hamid Sayar may publish in the future.

Co-authorship network of co-authors of Hamid Sayar

This figure shows the co-authorship network connecting the top 25 collaborators of Hamid Sayar. A scholar is included among the top collaborators of Hamid Sayar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hamid Sayar. Hamid Sayar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Saliba, Antoine N., et al.. (2021). Does Race Play a Role in Complications and Outcomes of Philadelphia Chromosome-Negative Myeloproliferative Neoplasms?. Hematology/Oncology and Stem Cell Therapy. 15(2). 30–38. 6 indexed citations
4.
5.
Sayar, Hamid, et al.. (2018). Primary Myeloid Sarcoma of the Prostate: A Case Report and Literature Review. PMC.
6.
Komrokji, Rami S., Arlene S. Swern, David L. Grinblatt, et al.. (2017). Azacitidine in Lower-Risk Myelodysplastic Syndromes: A Meta-Analysis of Data from Prospective Studies. The Oncologist. 23(2). 159–170. 27 indexed citations
7.
Sayar, Hamid, et al.. (2017). Therapies for acute myeloid leukemia: vosaroxin. OncoTargets and Therapy. Volume 10. 3957–3963. 13 indexed citations
8.
Roboz, Gail J., Pau Montesinos, Dominik Selleslag, et al.. (2016). Design of the Randomized, Phase III, QUAZAR AML Maintenance Trial of CC-486 (Oral Azacitidine) Maintenance Therapy in Acute Myeloid Leukemia. Future Oncology. 12(3). 293–302. 29 indexed citations
9.
Sayar, Hamid, et al.. (2014). Pilot study of erlotinib in patients with acute myeloid leukemia. Leukemia Research. 39(2). 170–172. 5 indexed citations
10.
Zaid, Mohammad Abu, H. Scott Boswell, Larry D. Cripe, et al.. (2014). Phase I/II Study of Combination of Sorafenib, Vorinostat, and Bortezomib in Acute Myeloid Leukemia with FLT3-ITD Mutation or Monosomy 5, 7, or Complex Cytogenetics. Blood. 124(21). 976–976. 3 indexed citations
11.
12.
13.
Shanmugam, Rajasubramaniam, Padmaja Gade, Hamid Sayar, et al.. (2011). A Noncanonical Flt3ITD/NF-κB Signaling Pathway Represses DAPK1 in Acute Myeloid Leukemia. Clinical Cancer Research. 18(2). 360–369. 33 indexed citations
14.
Özdemir, Süleyman, et al.. (2011). Giant fibrovascular polyp of the hypopharynx: per-oral endoscopic removal. The Journal of Laryngology & Otology. 125(10). 1087–1090. 10 indexed citations
15.
Sayar, Hamid, Rebecca J. Chan, Christie M. Orschell, et al.. (2011). Thrice weekly azacitidine does not improve hematological responses in lower-risk myelodysplastic syndromes: A study of the Hoosier Oncology Group. Leukemia Research. 35(8). 1108–1110. 5 indexed citations
16.
Sayar, Hamid, et al.. (2010). Tumor MET Expression May Not Predict the Risk of Venous Thromboembolism in Cancer Patients. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics. 19(2). 93–97. 1 indexed citations
17.
Sayar, Hamid, Zhiyuan Shen, Melanie Royce, et al.. (2008). Phase I study of capecitabine in combination with cisplatin and irinotecan in patients with advanced solid malignancies. Investigational New Drugs. 27(2). 153–158. 1 indexed citations
18.
Sayar, Hamid, et al.. (2006). Fragmentation hemolytic anemia 8 years after replacement of ascending aorta with a sutureless intraluminal graft. American Journal of Hematology. 81(3). 175–177. 9 indexed citations
19.
Sayar, Hamid, Catherine Lhommé, & Claire F. Verschraegen. (2005). Malignant Adnexal Masses in Pregnancy. Obstetrics and Gynecology Clinics of North America. 32(4). 569–593. 24 indexed citations
20.
Quintana‐Murci, Lluís, Raphaëlle Chaix, R. Spencer Wells, et al.. (2004). Where West Meets East: The Complex mtDNA Landscape of the Southwest and Central Asian Corridor. The American Journal of Human Genetics. 74(5). 827–845. 317 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lucia Casarino Breakdown of academic impact, for papers by Giuseppe Lentini Breakdown of academic impact, for papers by Costanza Bosi Breakdown of academic impact, for papers by J.C. Murray Breakdown of academic impact, for papers by Steven Fabian Breakdown of academic impact, for papers by Marion E. Stone Breakdown of academic impact, for papers by Chimene Kesserwan Breakdown of academic impact, for papers by Sachiyo Nishida Breakdown of academic impact, for papers by Matthew E. Mealiffe Breakdown of academic impact, for papers by Sarah A. Bannon
Rankless by CCL
2026